Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Breast cancer
Closed
Phase 2
This trial is looking at a new drug called cabazitaxel for women with breast cancer that has spread to another part of the body. It is for women whose breast cancer cells have low or no amounts of . This is called HER2 negative breast cancer.
Recruitment start: 1 December 2014
Recruitment end: 20 April 2020
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Amit Bahl
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Sanofi Aventis
University Hospitals Bristol NHS Foundation Trust
Last reviewed: 17 May 2020
CRUK internal database number: 12650
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
